EvaThera: A Safe and Effective Targeted-Radiopharmaceutical Platform

Time: 2:00 pm
day: Day One

Details:

The EvaThera Platform:

  • Extends blood half-life of novel targeting radiopharmaceutical enhances target uptake with low toxicity in non-target organ
  • Improves therapeutic and diagnostic outcomes in SSTR2 and integrin

Speakers: